CJC-1295 MOD GRF 1-29 (Without DAC) 2mg — Premium Research Peptide | 2mg Lyophilized Powder | ≥98% Purity | EU & UK Delivery
CJC 1295 without DAC 2mg – Research Grade Peptide
CJC 1295 without DAC 2mg, also known as Modified GRF (1-29), is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), designed for endocrine system research. This 29 amino acid peptide is a truncated form of GHRH, suitable for scientific study.
- Product Name: CJC 1295 without DAC 2mg
- Catalogue Number: CJC2-024
- Molecular Formula: C152H252N44O42
- Molecular Weight: 3368.7 g/mol
- Purity: 98%
- CAS Number: 863288-34-0
- Form: Lyophilised Solid
Description and Usage:
CJC 1295 without DAC 2mg is prepared for research use, with each lyophilised vial intended for reconstitution as needed for experimental applications. Orders are processed promptly to support ongoing research efforts.
Legal and Safety Information:
All UK-Peptides products, such as CJC 1295 without DAC 2mg, are developed exclusively for scientific research purposes. We strictly prohibit inquiries about human consumption to maintain safety and comply with legal standards.
For researchers seeking to buy peptide online Peptology for investigations into muscle regeneration, satellite cell biology, or tissue repair mechanisms, peptology.store offers this premium research compound with comprehensive documentation, including Certificates of Analysis and batch-specific purity data. Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.
Chemical and Product Specifications
| Specification | Detail |
|---|---|
| Product Name | CJC-1295 MOD GRF 1-29 (Without DAC) |
| Quantity | 2 mg per vial |
| Purity | ≥98% HPLC, subject to batch-specific COA |
| Form | Lyophilized powder |
| Appearance | White to off-white lyophilized powder |
| Molecular Weight | Approximately 3.36 kDa |
| CAS Number | Verify against batch-specific documentation |
| Molecular Formula | Verify against the manufacturer’s analytical documentation |
| Amino Acid Sequence | Modified GRF 1-29 / CJC-1295 (Without DAC); verify exact sequence against the batch COA |
| Structure | Synthetic peptide analogue of growth hormone–releasing hormone (GHRH) |
| PEGylation | None |
| DAC Modification | Without DAC |
| Primary Research Target | Growth hormone–releasing hormone receptor (GHRHR) |
| Key Research Areas | Growth hormone secretion, GHRH signaling, pituitary research, endocrine signaling, and peptide pharmacology |
| Storage (Lyophilized) | Follow manufacturer-validated storage conditions and batch-specific documentation |
| Storage (Reconstituted) | Follow validated laboratory stability data; avoid repeated freeze-thaw cycles |
| Shelf Life | Batch-specific; refer to manufacturer’s documented expiry |
| Intended Use | Research and laboratory use only |
| Documentation | Certificate of Analysis with applicable analytical and purity data |
Stability and Handling Guidelines
Lyophilized Powder Storage:
Store lyophilized CJC-1295 MOD GRF 1-29 (Without DAC) according to the manufacturer’s validated storage conditions. Keep the material dry, protected from excessive light and moisture, and maintain the temperature specified on the batch-specific Certificate of Analysis.
Handling:
Handle the lyophilized peptide using standard laboratory procedures appropriate for research peptides. Minimize unnecessary exposure to heat, moisture, and repeated temperature fluctuations.
Reconstitution:
- Allow the vial and compatible laboratory solvent to equilibrate according to the laboratory’s handling protocol.
- Use an appropriate research-grade solvent or buffer compatible with the intended experiment.
- Add the solvent carefully to minimize foaming.
- Gently mix or swirl until the material is completely dissolved; avoid vigorous agitation.
- Label the preparation with the compound name, concentration, batch number, and preparation date.
- Store the resulting preparation according to validated laboratory stability data.
Reconstituted Solution Storage:
Store reconstituted CJC-1295 MOD GRF 1-29 (Without DAC) according to validated stability data for the specific formulation. Avoid unnecessary repeated freeze-thaw cycles.
Protection From Light and Moisture:
- Keep the vial tightly sealed when not in use.
- Store in the original container whenever practical.
- Protect the material from excessive light and moisture.
- Follow the manufacturer’s batch-specific storage and handling instructions.
Key Research Applications
- Growth Hormone Research: Investigate mechanisms regulating growth hormone secretion.
- GHRH Signaling: Study signaling associated with growth hormone–releasing hormone pathways.
- Pituitary Research: Investigate peptide-mediated regulation of pituitary somatotroph activity.
- Endocrine Research: Explore interactions within the hypothalamic-pituitary growth hormone axis.
- Peptide Pharmacology: Study the structure, activity, stability, and pharmacological characteristics of GHRH analogues.
- Growth Hormone Secretion Models: Examine experimental changes in growth hormone release under controlled laboratory conditions.
- Receptor Signaling: Investigate interactions with the growth hormone–releasing hormone receptor (GHRHR).
- Comparative Peptide Research: Compare MOD GRF 1-29 with other GHRH analogues and peptide modifications.
Frequently Asked Questions
Q: What is CJC-1295 MOD GRF 1-29 (Without DAC)?
A: CJC-1295 MOD GRF 1-29 (Without DAC) is a synthetic modified analogue of growth hormone–releasing hormone (GHRH) used in laboratory research involving GHRH signaling and growth hormone secretion.
Q: What does “Without DAC” mean?
A: “Without DAC” indicates that the peptide does not contain the Drug Affinity Complex (DAC) modification associated with longer-acting CJC-1295 formulations. It is therefore generally classified separately from DAC-containing CJC-1295 compounds.
Q: What is the primary research target?
A: The principal research target is the growth hormone–releasing hormone receptor (GHRHR). Research focuses on receptor-mediated signaling and its relationship to growth hormone secretion.
Q: What purity level should be expected?
A: Purity should be confirmed using the batch-specific Certificate of Analysis. Where a product is specified as ≥98% purity, the corresponding HPLC analytical result should be documented for the particular batch.
Q: How should CJC-1295 MOD GRF 1-29 (Without DAC) be stored?
A: Storage should follow the manufacturer’s validated conditions and batch-specific documentation. Lyophilized material should generally be protected from moisture, excessive light, and temperature fluctuations.
Q: How does MOD GRF 1-29 differ from PEG-MGF?
A: They are different research peptides with different biological targets. MOD GRF 1-29 is a GHRH analogue investigated primarily in relation to GHRHR and growth hormone signaling, whereas PEG-MGF is a PEG-modified form of an MGF-related peptide investigated in muscle and tissue biology.
Q: What research areas commonly use MOD GRF 1-29?
A: Research applications include growth hormone secretion studies, GHRH/GHRHR signaling, pituitary biology, endocrine research, peptide pharmacology, and comparative studies of GHRH analogues.
Q: Is CJC-1295 MOD GRF 1-29 (Without DAC) intended for human use?
A: The product should be represented as a research-use compound only unless a specific formulation has the appropriate regulatory authorization for another purpose. It should not be presented as an approved treatment or as having established clinical benefits.
Q: What documentation should accompany a research batch?
A: Appropriate documentation may include a batch-specific Certificate of Analysis, HPLC purity data, mass-spectrometry identity confirmation, batch number, manufacturing information, and validated storage specifications.
Q: Do you ship CJC-1295 MOD GRF 1-29 (Without DAC) to EU countries?
A: Yes. As a dedicated peptide supplier, we ship CJC-1295 MOD GRF 1-29 (Without DAC) to all European Union member states with our guaranteed 48 hour delivery peptide service. Our Peptology fulfilment centre ensures rapid delivery without customs delays. All shipments use protective packaging to maintain compound integrity during transit.
Q: What documentation do you provide with CJC-1295 MOD GRF 1-29 (Without DAC) orders?
A: Every order includes a Certificate of Analysis (COA) with batch-specific purity data. Additional documentation, including HPLC chromatograms and mass spectrometry data, may be available upon request for researchers requiring comprehensive analytical verification.
Q: Do you offer bulk quantities of CJC-1295 MOD GRF 1-29 (Without DAC) for institutional research?
A: Yes. We accommodate bulk orders for research institutions. Contact our team now for volume pricing, custom requirements, and supply agreements for ongoing research programs.
Advance Your Research with CJC-1295 MOD GRF 1-29 (Without DAC)
peptology.store is your trusted source for CJC-1295 MOD GRF 1-29 (Without DAC), a research peptide used in studies investigating growth hormone–releasing hormone (GHRH) signaling, growth hormone secretion, pituitary function, and peptide pharmacology.
Whether you are studying GHRH/GHRHR signaling, designing controlled growth hormone secretion experiments, investigating pituitary biology, or comparing modified GHRH analogues, this research compound is intended to provide consistent, documented material for laboratory investigations.
Order today and experience the peptology.store difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.
